Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Gains from Sales and Divestitures: 2018-2024

Historic Gains from Sales and Divestitures for Fortress Biotech (FBIO) over the last 7 years, with Dec 2024 value amounting to $137,655.

  • Fortress Biotech's Gains from Sales and Divestitures rose 618.95% to $737,132 in Q3 2025 from the same period last year, while for Sep 2025 it was $737,132, marking a year-over-year increase of 618.95%. This contributed to the annual value of $137,655 for FY2024, which is 24.30% down from last year.
  • Latest data reveals that Fortress Biotech reported Gains from Sales and Divestitures of $137,655 as of FY2024, which was down 24.30% from $181,831 recorded in FY2023.
  • Fortress Biotech's Gains from Sales and Divestitures' 5-year high stood at $1.8 million during FY2022, with a 5-year trough of $137,655 in FY2024.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $181,831 (2023), whereas its average is $691,708.
  • Per our database at Business Quant, Fortress Biotech's Gains from Sales and Divestitures surged by 146.42% in 2022 and then crashed by 89.64% in 2023.
  • Over the past 5 years, Fortress Biotech's Gains from Sales and Divestitures (Yearly) stood at $384,958 in 2020, then soared by 85.07% to $712,449 in 2021, then surged by 146.42% to $1.8 million in 2022, then slumped by 89.64% to $181,831 in 2023, then decreased by 24.30% to $137,655 in 2024.